Cabaletta Bio
CABA
55 hedge funds and large institutions have $202M invested in Cabaletta Bio in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
18% more capital invested
Capital invested by funds: $171M → $202M (+$31M)
2% more funds holding
Funds holding: 54 → 55 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.81% less ownership
Funds ownership: 68.03% → 67.22% (-0.81%)
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.14M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.42M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.06M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$480K |
| 5 |
State Street
Boston,
Massachusetts
|
+$479K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
5VM
5AM Venture Management
San Francisco,
California
|
-$3.87M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.9M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.11M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$599K |
| 5 |
Squarepoint
New York
|
-$296K |
CABA Hedge Fund Activity: Q4 2020 in Review
55 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q4 2020, worth a combined $202M — up 18% from $171M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CABA positions and 5 closed out — a net gain of 1 holder — while 17 added to existing stakes and 18 trimmed.
The largest buyer was BlackRock, adding an estimated $4.14M. The largest seller was 5AM Venture Management, cutting an estimated $3.87M.
- 55 institutional investors held Cabaletta Bio (CABA) as of Q4 2020, up from 54 in Q3 2020.
- Funds reported $202M of Cabaletta Bio stock for Q4 2020, up 18% quarter-over-quarter.
- 6 funds opened new Cabaletta Bio positions in Q4 2020 and 5 closed out, a net change of +1 holder.
- The largest Cabaletta Bio buyer in Q4 2020 was BlackRock, an estimated $4.14M added.
- The largest Cabaletta Bio seller in Q4 2020 was 5AM Venture Management, an estimated $3.87M sold.
Based on aggregated 13F filings for Q4 2020.